NASH (nonalcoholic steatohepatitis)
is a metabolic-related liver disease. It is the result of modern lifestyles, and is closely related to the triple epidemic of obesity, diabetes, and pre-diabetes.
NASH AFFECTS AROUND 10%
OF ADULT POPULATION IN DEVELOPED COUNTRIES
In order to address unmet needs related to this disease that deserves a wider exposure, GENFIT leads a public health initiative aimed at producing
and disseminating essential medical knowledge, toward a targeted audience:
> All physician specialties within the medical community
that will be in charge of NASH patients;
> Patients and their families,
who also need to understand causes, mechanisms and consequences of the disease,
to fully appreciate the importance of an early diagnosis and a treatment well-suited to
sets up an endowment fund as a tool for this long-term endeavor which allows financing and managing relevant disease awareness actions in the NASH space.
While GENFIT is the driving force behind this public health initiative, collaborative work is one of its cornerstones. All worthwhile resources are therefore welcome to support this effort.
Jean-François Mouney, President
The NASH Education ProgramTM